AlphaYouDB
Congress trade
Rep. Donald Beyer (D-VA) bought $1K-$15K of Editas Medicine, Inc. (EDIT) stock
Donald Beyer, U.S. Representative (D-VA), disclosed a purchase of Editas Medicine, Inc. (EDIT) stock worth $1K-$15K in a STOCK Act filing on Dec 1, 2020.
The trade happened on Nov 17, 2020, 14 days before it was made public.
EDIT has moved -90.9% since the trade date, from $28.75 to $2.62 (Oct 2, 2026 close).
- Traded
- Nov 17, 2020
- Disclosed
- Dec 1, 2020
- Filing delay
- 14 days
- Price since
- -90.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (43)
- BuyAAPL$1K-$15KDec 1, 2020
- BuyAAPL$1K-$15KDec 1, 2020
- BuyACN$1K-$15KDec 1, 2020
- BuyASML$1K-$15KDec 1, 2020
- BuyCGNX$1K-$15KDec 1, 2020
- BuyCOST$1K-$15KDec 1, 2020
- BuyCOST$1K-$15KDec 1, 2020
- BuyCYRX$1K-$15KDec 1, 2020
- BuyCYRX$1K-$15KDec 1, 2020
- BuyDAIUF$1K-$15KDec 1, 2020
- BuyDAIUF$1K-$15KDec 1, 2020
- BuyDIS$1K-$15KDec 1, 2020
- BuyECL$1K-$15KDec 1, 2020
- BuyEL$1K-$15KDec 1, 2020
- BuyEL$1K-$15KDec 1, 2020
- BuyFANUF$1K-$15KDec 1, 2020
- BuyFANUF$1K-$15KDec 1, 2020
- BuyFANUF$1K-$15KDec 1, 2020
- BuyFANUF$1K-$15KDec 1, 2020
- BuyFANUF$1K-$15KDec 1, 2020
More EDIT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.